Advisory Mandate
The Central Real Estate Group is a Swiss real estate company domiciled in Zurich. The group invests in visionary and sustainable development projects in inner-city locations in Swiss economic centers.
Central Real Estate Holding AG was founded by Swiss pension funds, investment foundations, and insurance companies.
The acquisition of the Klybeck site from Novartis Pharma AG by the subsidiary Rhystadt AG is the Group’s first project.